ECTRIMS 2016

Psychiatric Disorders Common in Pediatric MS, Demyelinating Diseases

Psychiatric Disorders Common in Pediatric MS, Demyelinating Diseases

By

Notably, patients who had documented psychotic and psychiatric disorders were more likely to be diagnosed with a demyelinating disease.

Dimethyl-Fumarate May Maintain NEDA After Natalizumab Discontinuation

Dimethyl-Fumarate May Maintain NEDA After Natalizumab Discontinuation

By

Over 90% of participants achieved NEDA-3 after being transitioned to dimethyl-fumarate from natalizumab.

Smoking May Accelerate White Matter Damage in Progressive MS

Smoking May Accelerate White Matter Damage in Progressive MS

By

The relationship between microstructural damage in NAWM and clinical measures was less clear, suggesting another mechanism.

Enriching Experiences May Protect Against Cognitive Decline in MS

Enriching Experiences May Protect Against Cognitive Decline in MS

By

Researchers examined whether the cognitive reserve hypothesis could predict cognitive decline, gray matter volume changes, and white matter volume changes in MS patients.

High-Fat Diets May Increase Relapse Risk in Pediatric MS

High-Fat Diets May Increase Relapse Risk in Pediatric MS

By

High-fat diets may increase the risk of relapse in children with MS, while high-vegetable diets may be protective.

Genetic Risk Score Identifies Pediatric Patients With Greater MS Relapse Risk

Genetic Risk Score Identifies Pediatric Patients With Greater MS Relapse Risk

By

Six polymorphisms were found to be strongly associated with vitamin D levels in the patient population.

Axon Diameter May Help Detect, Track Multiple Sclerosis

Axon Diameter May Help Detect, Track Multiple Sclerosis

By

Axon diameter dynamics may serve as a novel biomarker for MS disease course.

Early Tx Exposure May Prevent Progression in Pediatric Clinically Isolated Syndrome

Early Tx Exposure May Prevent Progression in Pediatric Clinically Isolated Syndrome

By

Patients at the greatest risk of disability progression were older than 12 years, and had minimal exposure to DMTs.

BMI, Lipid Levels Influence Multiple Sclerosis Disease Course

BMI, Lipid Levels Influence Multiple Sclerosis Disease Course

By

Higher BMI and lipid levels were associated with greater risk of relapse and disability progression.

Sign Up for Free e-newsletters



CME Focus